glutathione platinum resistance A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin IMMUNOCAL PLATINUM ROS-mediated SRMS activation confers platinum
ROS mediated SRMS activation confers platinum resistance in ovarian cancer Oncogene Long noncoding RNA GDIL acts as a scaffold for CHAC1 and XRN2 to promote platinum resistance of colorectal cancer through inhibition of glutathione degradation Cell Death & Disease Clinical Perspectives on Platinum Resistance Drugs Springer Nature Link Role of Glutathione in Cancer: From Mechanisms to Therapies
Pay in 4 interest-free payments of $6.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



